Takara Bio Inc. (TYO:4974)
1,142.00
0.00 (0.00%)
Jun 3, 2026, 3:30 PM JST
Takara Bio Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 20,451 | 29,549 | 35,416 | 51,847 | 23,633 |
Cash & Short-Term Investments | 20,451 | 29,549 | 35,416 | 51,847 | 23,633 |
Cash Growth | -30.79% | -16.57% | -31.69% | 119.38% | -9.08% |
Receivables | 10,807 | 14,017 | 11,285 | 12,448 | 17,804 |
Inventory | 11,620 | 12,439 | 11,850 | 11,087 | 24,065 |
Other Current Assets | 2,000 | 1,674 | 4,208 | 2,187 | 2,639 |
Total Current Assets | 44,878 | 57,679 | 62,759 | 77,569 | 68,141 |
Property, Plant & Equipment | 62,744 | 56,954 | 49,075 | 40,956 | 36,395 |
Long-Term Investments | 968 | 1,727 | 556 | 560 | 476 |
Goodwill | 12,432 | 6,516 | 6,488 | 6,674 | 6,309 |
Other Intangible Assets | 12,369 | 1,455 | 1,539 | 2,373 | 2,850 |
Long-Term Deferred Tax Assets | 265 | 1,003 | 833 | 1,067 | 1,539 |
Other Long-Term Assets | 2 | - | 2 | 3 | 2 |
Total Assets | 133,658 | 125,334 | 121,252 | 129,202 | 115,712 |
Accounts Payable | 1,449 | 1,652 | 1,543 | 2,323 | 1,959 |
Accrued Expenses | 567 | 1,003 | 962 | 1,065 | 923 |
Current Portion of Leases | 207 | 193 | 180 | 151 | 137 |
Current Income Taxes Payable | 1,503 | 1,984 | 2,047 | 5,077 | 9,941 |
Other Current Liabilities | 4,060 | 2,299 | 2,436 | 5,759 | 4,420 |
Total Current Liabilities | 7,786 | 7,131 | 7,168 | 14,375 | 17,380 |
Long-Term Debt | 10,000 | - | - | - | - |
Long-Term Leases | 776 | 908 | 788 | 821 | 910 |
Pension & Post-Retirement Benefits | 1,027 | 989 | 1,102 | 992 | 788 |
Long-Term Deferred Tax Liabilities | 1,463 | - | - | 179 | 198 |
Other Long-Term Liabilities | 8,639 | 459 | 411 | 382 | 373 |
Total Liabilities | 29,691 | 9,487 | 9,469 | 16,749 | 19,649 |
Common Stock | 14,965 | 14,965 | 14,965 | 14,965 | 14,965 |
Additional Paid-In Capital | 32,893 | 32,893 | 32,893 | 32,893 | 32,893 |
Retained Earnings | 40,819 | 52,465 | 53,471 | 57,047 | 45,009 |
Comprehensive Income & Other | 14,988 | 15,176 | 10,175 | 7,313 | 3,005 |
Total Common Equity | 103,665 | 115,499 | 111,504 | 112,218 | 95,872 |
Minority Interest | 302 | 348 | 279 | 235 | 191 |
Shareholders' Equity | 103,967 | 115,847 | 111,783 | 112,453 | 96,063 |
Total Liabilities & Equity | 133,658 | 125,334 | 121,252 | 129,202 | 115,712 |
Total Debt | 10,983 | 1,101 | 968 | 972 | 1,047 |
Net Cash (Debt) | 9,468 | 28,448 | 34,448 | 50,875 | 22,586 |
Net Cash Growth | -66.72% | -17.42% | -32.29% | 125.25% | -9.12% |
Net Cash Per Share | 78.63 | 236.25 | 286.08 | 422.50 | 187.57 |
Filing Date Shares Outstanding | 120.42 | 120.42 | 120.42 | 120.42 | 120.42 |
Total Common Shares Outstanding | 120.42 | 120.42 | 120.42 | 120.42 | 120.42 |
Working Capital | 37,092 | 50,548 | 55,591 | 63,194 | 50,761 |
Book Value Per Share | 860.89 | 959.17 | 925.99 | 931.92 | 796.18 |
Tangible Book Value | 78,864 | 107,528 | 103,477 | 103,171 | 86,713 |
Tangible Book Value Per Share | 654.93 | 892.97 | 859.33 | 856.79 | 720.11 |